MARKET

AYLA

AYLA

Ayala Pharmaceuticals, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.30
+0.23
+1.76%
Closed 16:00 08/05 EDT
OPEN
13.32
PREV CLOSE
13.07
HIGH
13.32
LOW
12.70
VOLUME
7.08K
TURNOVER
--
52 WEEK HIGH
16.50
52 WEEK LOW
9.15
MARKET CAP
169.18M
P/E (TTM)
-7.5719
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AYLA stock price target is 21.13 with a high estimate of 25.00 and a low estimate of 12.50.

EPS

AYLA News

More
Ayala Pharmaceuticals to Present Updated Data from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of R/M Adenoid Cystic Carcinoma at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
REHOVOT, Israel and WILMINGTON, Del., July 27, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and agg
GlobeNewswire · 07/27 12:01
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)
Benzinga · 07/08 11:31
Ayala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire · 06/22 13:00
Ayala Pharmaceuticals Q1 EPS $(1.32)
Benzinga · 06/22 12:20
Why This Ayala Pharmaceuticals Analyst Is Bullish
The Phase 2 study of Ayala Pharmaceuticals Inc’s (NASDAQ: AYLA) AL101 candidate is scheduled to begin in the back half of this year.
Benzinga · 06/10 15:31
Why This Ayala Pharmaceuticals Analyst Is Bullish
The Phase 2 study of Ayala Pharmaceuticals Inc's (NASDAQ: AYLA) AL101 candidate is scheduled to begin in the back half of this year.Although the first data from the study could come during 2021, a safety assessment of the first six patients may be available by
Benzinga · 06/10 15:30
Raymond James Initiates Coverage On Ayala Pharmaceuticals with Outperform Rating, Announces Price Target of $24
Raymond James analyst Dane Leone initiates coverage on Ayala Pharmaceuticals (NASDAQ:AYLA) with a Outperform rating and announces Price Target of $24.
Benzinga · 06/10 11:13
Oppenheimer Initiates Coverage On Ayala Pharmaceuticals with Outperform Rating, Announces Price Target of $23
Oppenheimer analyst Jay Olson initiates coverage on Ayala Pharmaceuticals (NASDAQ:AYLA) with a Outperform rating and announces Price Target of $23.
Benzinga · 06/02 11:49

Industry

Biotechnology & Medical Research
+0.18%
Pharmaceuticals & Medical Research
+0.35%

Hot Stocks

Symbol
Price
%Change

About AYLA

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company. It is focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. The Company’s portfolio of product candidates include AL101 and AL102, which targets the aberrant activation of the Notch pathway with gamma secretase inhibitors. The Company’s lead product candidate, AL101, is being developed as a potent, selective, injectable small molecule gamma secretase inhibitor (GSI). It is evaluating AL101 as a monotherapy in an open-label Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma (R/M ACC) for patients bearing Notch-activating mutations. The Company refer this trial as the ACCURACY trial. The Company uses advanced sequencing to identify patients with Notch-activating mutations, an approach that will enable it to target the patient population with cancers.
More

Webull offers kinds of Ayala Pharmaceuticals Inc stock information, including NASDAQ:AYLA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYLA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AYLA stock methods without spending real money on the virtual paper trading platform.